Glycodendrimeric ligands of c-type lectin receptors as therapeutic agents in experimental cancer.
Pospisil
M
M
Institute of Microbiology, Div. Immunology, Lab. Natural Cell Immunity, Academy of Sciences of the Czech Republic, Prague.
Vannucci
L
L
Fiserova
A
A
Krausova
K
K
Horvath
O
O
Kren
V
V
Mosca
F
F
Lindhorst
T K
TK
Sadalapure
K
K
Bezouska
K
K
D000818:Animals; D000954:Antigens, Surface / Q000378:metabolism; D015179:Colorectal Neoplasms / Q000276:immunology / Q000628:therapy; D006001:Glycoconjugates / Q000737:chemistry / Q000276:immunology / Q000627:therapeutic use; D006031:Glycosylation; D007167:Immunotherapy; D007694:Killer Cells, Natural / Q000276:immunology; D037102:Lectins / Q000737:chemistry / Q000378:metabolism*; D037181:Lectins, C-Type; D008024:Ligands; D008546:Melanoma, Experimental / Q000276:immunology / Q000628:therapy; D051379:Mice; D008810:Mice, Inbred C57BL; D055651:NK Cell Lectin-Like Receptor Subfamily B; D051381:Rats; D011975:Receptors, Mitogen / Q000378:metabolism*
D000954:Antigens, Surface; D006001:Glycoconjugates; D037102:Lectins; D037181:Lectins, C-Type; D008024:Ligands; D055651:NK Cell Lectin-Like Receptor Subfamily B; D011975:Receptors, Mitogen